Key Takeaways

  • CMS permits nurse practitioners (NPs), physician assistants (PAs), clinical nurse specialists (CNSs), certified registered nurse anesthetists (CRNAs), and certified nurse-midwives (CNMs) to supervise Level 2 contrast studies within state scope-of-practice limits.
  • State law determines whether an NP or PA can supervise contrast at a specific facility.
  • Billing and coding requirements vary across physician offices, independent diagnostic testing facilities (IDTFs), and hospital outpatient departments.
  • Washington’s HB 2113, effective June 2026, explicitly authorizes advanced registered nurse practitioners (ARNPs) and PAs to directly supervise contrast administration.
  • Facilities must document each nonphysician practitioner’s (NPP’s) credentials and legal basis for supervision eligibility.

Imaging centers weighing staffing options for contrast-enhanced CT and MRI often ask whether a nurse practitioner or physician assistant already on staff could take over supervision duties. Medicare’s answer is genuinely yes, but with guardrails that matter more than the headline suggests. Knowing exactly where those guardrails sit can save a facility from a compliance misstep that is costly to unwind.

The CMS Rule That Changed Supervision

For years, only physicians could satisfy the direct supervision requirement for Level 2 diagnostic tests, including contrast-enhanced CT and MRI. That changed with policy updates that took effect in 2021 and were made permanent under the 2026 Physician Fee Schedule and Outpatient Prospective Payment System final rules. CMS now recognizes a defined group of nonphysician practitioners as eligible to provide direct supervision for these studies, including virtually under the permanent rule.

ContrastConnect, a remote contrast supervision provider, notes that this expanded eligibility does not grant blanket authority. Nonphysician practitioners can supervise these studies only to the extent permitted by their scope of practice and applicable state law. This distinction is central to determining whether an NP or a PA can supervise contrast administration at a particular facility.

Facilities that overlook this condition risk assuming a nationwide authorization exists when eligibility actually depends on state law and the facility’s circumstances. ContrastConnect’s guidance on NP and PA contrast supervision explains how these requirements affect operational and compliance decisions.

Which Practitioners Qualify Under CMS

NPs, CNSs, PAs, CRNAs, and CNMs

The CMS list of eligible nonphysician practitioners is specific. It includes nurse practitioners, clinical nurse specialists, physician assistants, certified registered nurse anesthetists, and certified nurse-midwives. Each of these practitioner types can, in principle, provide the direct supervision that Level 2 tests require, standing alongside physicians rather than replacing the physician option entirely.

This list matters because it draws a clear boundary. A registered nurse or radiologic technologist, however experienced, does not appear on it. Facilities building a supervision plan around nonphysician staff need to confirm the specific credential held by the person in that role, since CMS does not extend this authorization beyond the five practitioner categories named in the rule.

Direct Supervision vs. Personally Performing a Test

Supervising a diagnostic test and personally performing one are separate functions under CMS policy. When an NP, CNS, or PA supervises a contrast study, the supervision rule applies. When one of these practitioners personally performs the test itself, a different set of practitioner-category and state requirements comes into play.

This distinction is easy to blur in daily practice but important for compliance recordkeeping. A facility should document which function an NPP is fulfilling in each case, since the regulatory basis supporting that role differs depending on whether supervision or direct performance is involved.

Why Scope of Practice Still Controls

State Law Determines Eligibility

Scope of practice for NPs and PAs is set at the state level, and it varies considerably from one state to the next. Some states grant NPs full practice authority, allowing them to oversee a broad range of clinical functions without a physician’s sign-off. Others require a collaborative or supervisory agreement before an NP can take on certain duties. PA scope of practice follows a similar pattern, with meaningful differences in how much independent authority a state recognizes.

Because of this patchwork, the same CMS rule can produce different real-world outcomes depending on where a facility operates. An NP who can clearly supervise contrast administration in one state may face an unclear or unresolved question in another, even though the federal rule itself has not changed.

When the Law Is Unclear, Ask First

Many states have not directly addressed whether contrast supervision falls within an NP’s or PA’s authorized scope. That silence creates ambiguity rather than permission. Before assigning an NP or PA to the contrast-supervising role, a facility should confirm the answer with legal counsel or the state licensing board rather than assuming the broadest possible reading of the law applies.

This step is not optional paperwork. A supervision arrangement that later turns out to exceed a practitioner’s authorized scope can expose a facility to billing and compliance problems well after the contrast studies in question have already been performed.

Setting and Billing Rules Differ

Physician Offices, IDTFs, and Hospital Outpatient Departments

The NPP supervision authorization applies across physician offices and Independent Diagnostic Testing Facilities under the Physician Fee Schedule, and in hospital outpatient departments under the OPPS final rule. The practical requirements differ across these settings, though. An IDTF, for example, requires a supervising physician who is board-eligible or board-certified when a physician fills that role, a standard that shapes how an IDTF structures its overall supervision model even when an NPP is involved in other capacities.

Direct supervision in an office setting requires the supervising practitioner to be present in the office suite and immediately available throughout the service, though not necessarily in the room where the test takes place. That standard applies whether the supervisor is a physician or an eligible NPP, and it is worth confirming against the specific setting a facility operates in before finalizing any arrangement.

Confirm Coding With Your Billing Team

Billing treatment for NPP-supervised contrast studies is not uniform. In a physician office setting, a study supervised by an NPP may be billed as an incident-to service under the supervising physician’s National Provider Identifier, or billed under the NPP’s own NPI at a reduced rate. Which path applies depends on the specifics of the arrangement and the setting.

  • Confirm which NPI should be used for billing before the first NPP-supervised study is performed.
  • Verify whether incident-to billing rules apply in the facility’s specific setting.
  • Check that coding staff understand the difference between physician-supervised and NPP-supervised claims.

Getting this wrong does not just create a paperwork headache. It can result in claims being billed incorrectly for months before anyone notices the pattern, so looping in the billing team early is a practical safeguard rather than an extra formality.

How States Are Handling NPP Supervision

Washington’s HB 2113 Explicitly Allows It

Washington offers one of the clearest examples of a state resolving the ambiguity that trips up facilities elsewhere. HB 2113 took effect in June 2026 and explicitly permits ARNPs and PAs to directly supervise contrast administration, subject to the conditions the law lays out. Because the state law and the CMS rule align cleanly here, facilities in Washington face far less uncertainty than those operating in states where the scope-of-practice question remains unaddressed.

Other States Impose Stricter Conditions

Other states take a more layered approach. New Jersey’s diagnostic testing regulations allow contrast tests delegated to a trained radiologic technologist to proceed when a physician, physician assistant, or advanced practice nurse with the necessary education and training is present in the office suite, except in a documented emergency. Alabama takes a different structure entirely for virtual supervision: a board-certified, Alabama-licensed radiologist must provide real-time audio and video supervision of contrast injection, while an appropriately trained RN, CRNP, PA, or non-radiologist physician must be physically present on-site to respond if a contrast reaction occurs.

These examples show there is no single template for how states handle NPP involvement in contrast supervision. A facility operating in multiple states cannot assume the same staffing model will satisfy every jurisdiction’s requirements, which makes a state-by-state review a necessary part of any expansion plan.

Documenting NPP Supervision Correctly

CMS requires documentation of supervision for any Medicare-billable contrast study, and that requirement does not soften when the supervisor is an NPP rather than a physician. Supervision records should capture the practitioner’s credentials, the specific authorization under which they are supervising, and the basis for their eligibility under the applicable state law.

This documentation serves a dual purpose. It supports a clean billing trail, and it gives a facility a defensible record if a surveyor or payer later asks why a particular NP or PA was assigned to the supervising role for a given study. Facilities that build this documentation into their standard workflow, rather than treating it as an afterthought, tend to avoid the scramble that comes with reconstructing records after the fact.

The Bottom Line for Imaging Centers

CMS allows nurse practitioners, physician assistants, clinical nurse specialists, CRNAs, and CNMs to provide direct supervision for Level 2 contrast studies, including through virtual supervision where permitted. Whether this option works at a specific facility depends on the practitioner’s state-authorized scope of practice, applicable regulations, and the facility’s setting and billing structure. Washington’s HB 2113 provides one example of state-level authorization, but requirements vary by state.

For facilities reviewing their 2026 workflows, virtual supervision may offer a practical way to expand access to contrast-enhanced imaging while maintaining compliance. Before implementation, facilities should confirm practitioner eligibility, state requirements, billing procedures, and documentation protocols to select the supervision model best suited to their operations.

ContrastConnect

Las vegas
Las Vegas
NV
89109
United States

About The Author
NewsNetwork